Revolution Medicines, Inc. is 20.0x more valuable than Inhibrx, Inc. by market capitalization ($30.65 B vs $1.53 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | INBX | RVMD |
|---|---|---|
| Market cap | $1.53 B | $30.65 B |
| US-listed rank | #2303 | #454 |
| Revenue (latest FY) | $1.80M | $0.00 |
| Net income (latest FY) | -$241.36M | -$1.13B |
| Net margin | -13408.9% | - |
| SEC filings | 261 | 782 |
Revolution Medicines, Inc. is 20.0x more valuable than Inhibrx, Inc. by market capitalization ($30.65 B vs $1.53 B).
In their latest fiscal years, Inhibrx, Inc. reported $1.80M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Inhibrx, Inc. and Revolution Medicines, Inc., or browse the full rankings.